I-gel Plus Supraglottic Airway Device for Surgical Procedures in Prone Position
NCT ID: NCT06602817
Last Updated: 2025-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2024-10-01
2025-02-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim of this single-center non-inferior study is to assess the leak fraction of the i-gel Plus in patients undergoing surgery in prone position and to compare it with data from an existing prospective control cohort in patients undergoing surgery in supine position. Secondary aims are to investigate the oropharyngeal seal pressure and other secondary outcome parameters and to compare them with the control cohort.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
I-gel Plus Comparison Study
NCT07125677
A Comparison of the I-gel and Self-pressurised Air-Q Intubating Laryngeal Airway (Air-Q sp) in the Elderly Patients
NCT02260427
Risks of Gastroesophageal Reflux in the Endotracheal Intubation or the I-gel
NCT03634449
Efficiency of I-gel Supraglottic Airway Device in Supine and Lateral Decubitus Position in Obese Patient
NCT04119245
Comparison of Efficacy of Two Supraglottic Airway Devices: I-gel and the Self-pressurized Air-q in Elderly Patients
NCT04365192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgery in prone position
Patients undergoing elective surgery in prone position with i-gel Plus used for airway management
Exposure: prone position
Exposure: surgery in prone position
Surgery in supine position
Existing prospective control cohort with patients undergoing elective surgery in supine position with i-gel Plus used for airway management
Exposure: Supine position
Exposure: Surgery in supine position
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure: prone position
Exposure: surgery in prone position
Exposure: Supine position
Exposure: Surgery in supine position
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned airway management using a SGA
* Adult patients (age 18-89 years)
* ASA physical status 1-3
Exclusion Criteria
* Non-fasted patients
* Increased risk of aspiration or other contraindications for supraglottic mask ventilation
* Shared airway or intracavity open surgery
* Body mass index (BMI) \>35 kg/m2
* Inability to understand or sign informed consent
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Petzoldt, MD
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical-Center Hamburg Eppendorf
Hamburg, City state of Hamburg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-101343-BO-ff
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.